Avicanna is a Canadian biopharmaceutical company providing advanced cannabinoid solutions through an evidence-based approach. As a multinational organization with vertical integration, Avicanna is focused on utilizing scientific research related to plant-derived cannabinoid products through its internal research platforms, real-world evidence trials, and strategic collaborations with world-class research institutions.